In a related editorial, Dr. Giuseppe Biondi-Zoccai, from the University of Turin, Italy, and Dr. Marzia Lotrionte, from Catholic University in Rome, comment that several questions remain: "We don't know whether aspirin resistance is a true abnormal response or whether it reflects normal variability in drug activity. We also aren't clear whether aspirin resistance has a negative prognostic effect independent of more traditional risk factors, such as diabetes or obesity."
SOURCE: British Medical Journal, online January 18, 2008.
